← FDA Drug Approvals (Drugs@FDA)

AMPHOTERICIN B

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PARENTERAL · Approved 1995-03-31

Drug application

FDA Application #
ANDA064062
Application type
Abbreviated New Drug Application (Generic)
Brand name
AMPHOTERICIN B
Generic name
Amphotericin B
Active ingredients
AMPHOTERICIN B
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Discontinued
Sponsor
TEVA PARENTERAL
First approval
1995-03-31

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown